H ealth A lliance for P rudent P rescribing, Y ield And Use of anti-microbial D rugs I n the T reatment of Respiratory Tract Infections Proposal for EU DG Research, March 2006 Coordinator: Research Unit of General Practice, Odense, Denmark
% % 35-40% 40-45% 0-2 % % 0-5 % Prevalence of penicillin resistant pneumococci in Europe
Use of antibiotics in Europa 2002 DDD/1000 persons/day Gossens et al: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. The Lancet 2005
From: Emerging Infectious Diseases 2004;19(3):514 Penicillin-resistance in pneumococci Linear correlation between use of antibiotics and resistance
Resistant Strains Rare x x Resistant Strains Dominant Antimicrobial Exposure x x x x x x x x x x Selection for Antibiotic Resistance
HAPPY AUDIT Objective to reduce the occurrence of bacterial resistance by reducing prescribing of unnecessary antibiotics for respiratory tract infections by improving the use of appropriate antibiotics in suspected bacterial infections by improving the quality of diagnostic procedures for RTIs in general practice
Nordic region -Denmark 102 GPs -Sweden 77 GPs -Balticum region -Lithuania31 GPs -Kaliningrad39 GPs -Region Hispano-America: -Spain 309 GPs -Argentina60GPs -TOTAL 618 GPs
HAPPY AUDIT 618 GPs from 6 countries: - Nordic region -Denmark 102 GPs -Sweden 77 GPs - Balticum region -Lithuania31 GPs -Kaliningrad39 GPs - Region Hispano-America: -Spain 309 GPs -Argentina60 GPs
Kick-off meeting April 2007
Project time schedule Total project period: 3 years (April 2007 – March 2010) Analysis and conference Second registration of Patients First registration of Patients X Intervention: GPs and patients First invitation of GPs X
Project structure
Kaliningrad
Sweden
Lithuania
Spain
Denmark
Argentina
Intervention material for professionals Report with aggregated and individual results Happy Audit Guidelines Laboratory test instructions
Respiratory infections in general practice Results from 6 countries Reports in national language including individual results were sent to all paticipating GPs
My Practice
Centor criteria*: 1.Fever 2.Tender angular glands 3.Tonsil Coatings 4.Absence of cough *Described by dr. Robert Centor of the University of Alabama
Centor criteria and probability of Streptococci Number of Centor Criteria Probability of Streptococci Recommandation 02%No test – no treatment 13%No test – no treatment 28%Test and treat 319%Test and treat 441%Test and treat Patients with 0-1 Centor criteria should not be tested with Strep A
Use of Strep A in patients with odinophagia (painful swallowing) PatientsStrepA performed Percentage with Strep A Argentina % Denmark % Lithuania % Russia % Spain % Sweden % Total %
Strep A test in Denmark
Strep A test in Sweden
Reasons for antibiotic treatment of streptococ tonsillitis Reduce symptoms 0-1 Centor criteria: No effect 2-3 Centor criteria: Moderate effect (1-2 days) 4 Crentor criteria: Substantial effect (2-3 days) Prevent spread of streptococci Prevent complications Peritonsillar abscess (doubtfull : NNT >4000) Glomerulonephritis (no evidence for effect of antibiotics) Rheumatic fever (very seldom: NNT >4000)
Carriers of Streptococci 5-10% of individuals are asymptomatic carriers of streptococci A Strep A test will show that carriers have streptococci even though they are not causing symptoms. Generally, carriers should not be treated with antibiotics
Overuse of Strep A may lead to inappropriate antibiotic treatments Generally, Strep A should not be performed in: Asymptomatic carriers of Streptococci Patients with sore throat and less than 2 Centor criteria
Conclusion Denmark, Sweden: Overuse of Strep may lead to inappropriate antibiotic treatment and initiatives should be taken to reduce overuse of Strep A testing in general practice Spain, Argentina, Lithuania, Russia: Introduction of Strep A may leed to a lower prescribing in patients with sore thorat and initiatives should be taken to introduce Strep A in general practice
”The more you use it, - the faster you lose it” Burke JP, Lancet 1995;345:977
Collaboration in Europe about rational prescribing of antibiotics CHAMP Changing behaviour of Health care professionals And the general public towards a More Prudent use of anti- microbial agents.
Thank you
Validation study of Strep A in general practice in Barcelona Inclusded 182 patients with sore throat and ≥ 2 Centor criteria Tests: Throat Culture Strep A 44
Amigdalitis La validez de la prueba de Strep A pare diagnosticar Estrep betahem gr A Pos predictive value PPV = 38/48 = 79% Neg predictive value NPV = 132/134 = 98% Specificity: 132/142 = 93% Sensitivity: 38/40 = 95% Llor et al. Validación de una técnica antigénica rápida en el diagnóstico de la faringitis por esptreptococo beta- hemolitico del grupo A, Aten Primaria 2008
Nycocard CRP single test Axis-Shield, Norway Training through local distributors Instrument free during test period
Development of quality indicators for diagnosis and treatment of respiratory tract infections in general practice
Tonsillitis/pharyngitis Number of patients with a positive StrepA test Number of patients with acute tonsillitis/pharyngitis treated with antibiotics Number of patients treated with narrow-spectrum penicillin (J01CE) Number of patients with acute tonsillitis/pharyngitis treated with antibiotics
Experts – to do Rate to what extent they agree with the relevance of the 59 quality indicators – according to: A. Reducing antimicrobial resistance B. Clinical relevance for the patient* * Reducing symptoms and/or shortening duration of the actual course of the disease
Consensus The item should be retained: ≥ 75 % of participants scored the item ≥ 5 The item should be excluded: ≥ 75 % of participants scored the item ≤ 3 No consensus: items which failed to meet either of the above criteria
The final set of indicators 6 acute sinusitis 9 acute otitis media 6 acute tonsillitis/pharyngitis 7 acute lower respiratory tract infection (LRTI) 1 acute respiratory tract infection (RTI) 1 penicillin allergy 1 acute bronchitis 5 pneumonia 5 exacerbation of chronic obstructive pulmonary disease (COPD)
Number of doctors Number of patients registered Number of patients treated with antibiotics Argentina Denmark Lithauen Russia Spain Sweden Total
Conclusion Participating GPs Estimated: 400 Real number 618 Number of consultations registered Estimated Real number: Written material completed for all partners Guidelines, Patient brochures, Reports etc
Days with symptoms